1. Cross, M, Smith, E, Hoy, D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1323-1330.
Google Scholar | Crossref | Medline | ISI2. Brooks, PM . Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002;14:573-577.
Google Scholar | Crossref | Medline | ISI3. Altman, RD, Barthel, HR. Topical therapies for osteoarthritis. Drugs. 2011;71:1259-1279.
Google Scholar | Crossref | Medline4. Rodriguez-Merchan, EC . Topical therapies for knee osteoarthritis. Postgrad Med. 2018;130:607-612.
Google Scholar | Crossref | Medline5. McDonald, DD . Predictors of gastrointestinal bleeding in older persons taking nonsteroidal anti-inflammatory drugs: results from the FDA adverse events reporting system. J Am Assoc Nurse Pract. 2019;31:206–213.
Google Scholar | Crossref | Medline6. Schilling, A, Corey, R, Leonard, M, Eghtesad, B. Acetaminophen: old drug, new warnings. Cleve Clin J Med. 2010;77:19-27.
Google Scholar | Crossref | Medline | ISI7. Pepine, CJ, Gurbel, PA. Cardiovascular safety of NSAIDs: additional insights after precision and point of view. Clin Cardiol. 2017;40:1352-1356.
Google Scholar | Crossref | Medline8. Pérez Gutthann, S, García Rodríguez, LA, Raiford, DS, Duque Oliart, A, Ris Romeu, J. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med. 1996;156:2433-2439.
Google Scholar | Crossref | Medline9. Toupin April, K, Bisaillon, J, Welch, V, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev. 2019;5:CD005522.
Google Scholar | Medline10. Rannou, F, Pelletier, J-P, Martel-Pelletier, J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45:S18-S21.
Google Scholar | Crossref | Medline11. McCarthy, GM, McCarty, DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol. 1992;19:604-607.
Google Scholar | Medline | ISI12. Cohen, M, Wolfe, R, Mai, T, Lewis, D. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol. 2003;30:523-528.
Google Scholar | Medline | ISI13. Topp, R, Brosky, JA, Pieschel, D. The effect of either topical menthol or a placebo on functioning and knee pain among patients with knee OA. J Geriatr Phys Ther. 2013;36:92-99.
Google Scholar | Crossref | Medline | ISI14. Conaghan, PG, Bijlsma, JW, Kneer, W, Wise, E, Kvien, TK, Rother, M. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety. Curr Med Res Opin. 2014;30:599-611.
Google Scholar | Crossref | Medline15. Sarma, AV, Powell, GL, LaBerge, M. Phospholipid composition of articular cartilage boundary lubricant. J Orthop Res. 2001;19:671-676.
Google Scholar | Crossref | Medline | ISI16. Kawano, T, Miura, H, Mawatari, T, et al. Mechanical effects of the intraarticular administration of high molecular weight hyaluronic acid plus phospholipid on synovial joint lubrication and prevention of articular cartilage degeneration in experimental osteoarthritis. Arthritis Rheum. 2003;48:1923-1929.
Google Scholar | Crossref | Medline17. Kneer, W, Rother, M, Mazgareanu, S, Seidel, EJ, European IDEA-033 Study Group. A 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome® gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee. J Pain Res. 2013;6:743-753.
Google Scholar | Crossref | Medline18. Conaghan, PG, Dickson, J, Bolten, W, Cevc, G, Rother, M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology. 2013;52:1303-1312.
Google Scholar | Crossref | Medline | ISI19. Rother, M, Conaghan, PG. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J Rheumatol. 2013;40:1742-1748.
Google Scholar | Crossref | Medline20. Altman, R, Asch, E, Bloch, D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039-1049.
Google Scholar | Crossref | Medline21. Honvo, G, Bannuru, RR, Bruyère, O, et al. Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Drugs Aging. 2019;36(suppl 1):145-159.
Google Scholar | Medline22. Roos, EM, Roos, HP, Lohmander, LS, Ekdahl, C, Beynnon, BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88-96.
Google Scholar | Crossref | Medline | ISI